evidence: As a monkeypox outbreak quietly spreads in the U.S. and abroad, vaccines against the virus have become a hot commodity. Now, Bavarian Nordic, which has been at the forefront of the world’s monkeypox response, has lined up another major supply deal with the U.S. The U.S. Department of Health and Human Services (HHS) has locked up another 2.5 million doses of Bavarian Nordic’s smallpox and monkeypox vaccine Jynneos, bringing the government’s "rapidly available supply" to more than 4 million shots, HHS said in a recent release. [...] Aside from the doses of Bavarian Nordic’s Jynneos, the U.S. Strategic National Stockpile also has access to more than 100 million doses of Sanofi’s smallpox vaccine ACAM2000, which can be used to prevent monkeypox, too, under an expanded access protocol from the CDC.